CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities
Net loss	$ (1,709,533)	$ (1,715,290)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,106	1,107
Equity-based compensation expense	33,534	77,508
Changes in operating assets and liabilities:
Prepaid expenses and other assets	46,328	175,052
Accounts payable	254,645	111,104
Accrued expenses and other current liabilities	192,206	(3,436)
Net cash used in operating activities	(1,181,714)	(1,353,955)
Financing activities
Proceeds from issuance of equity securities, net	655,202	38
Payments on note payable	(109,636)	(172,788)
Net cash (used in) provided by financing activities	545,566	(172,750)
Net decrease in cash and cash equivalents	(636,148)	(1,526,705)
Cash, cash equivalents and restricted cash at beginning of period	2,434,528	5,899,910
Cash, cash equivalents and restricted cash at end of period	1,798,380	4,373,205
Non-cash investing and financing activities:
Cash paid for interest	4,094	4,019
Accrued issuance costs for issuance of equity securities	$ 429,032	$ 0